7.22
price down icon2.30%   -0.17
after-market Handel nachbörslich: 7.12 -0.10 -1.39%
loading

Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten

pulisher
May 29, 2025

(RNAZ) On The My Stocks Page - news.stocktradersdaily.com

May 29, 2025
pulisher
May 28, 2025

Transcode Therapeutics Appoints Dr. Phillip D. Zamore To Science Advisory Board - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board - citybiz

May 28, 2025
pulisher
May 28, 2025

TransCode Therapeutics appoints RNA expert to advisory board - Investing.com

May 28, 2025
pulisher
May 28, 2025

TransCode Therapeutics appoints RNA expert to advisory board By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

Alnylam Co-Founder Who Developed First FDA-Approved RNAi Drug Joins TransCode's Cancer Mission - Stock Titan

May 28, 2025
pulisher
May 24, 2025

TransCode Therapeutics (NASDAQ:RNAZ) Cut to “Sell” at Wall Street Zen - Defense World

May 24, 2025
pulisher
May 23, 2025

Certain Options of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Certain Warrants of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Certain Common Stock of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com

May 23, 2025
pulisher
May 19, 2025

When (RNAZ) Moves Investors should Listen - news.stocktradersdaily.com

May 19, 2025
pulisher
May 16, 2025

Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Nkarta (NKTX) and Kamada (KMDA) - The Globe and Mail

May 16, 2025
pulisher
May 14, 2025

Transcode Therapeutics (RNAZ) Trading Halted Pending News Announ - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Transcode Therapeutics (RNAZ) Trading Halted Pending News Announcement | RNAZ Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

TransCode Therapeutics (RNAZ) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Abeona Therapeutics (ABEO) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Intellia Therapeutics (NASDAQ:NTLA) Shares Down 6.1% After Analyst Downgrade - Defense World

May 14, 2025
pulisher
May 12, 2025

Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail

May 12, 2025
pulisher
May 09, 2025

(RNAZ) Investment Report - news.stocktradersdaily.com

May 09, 2025
pulisher
May 08, 2025

TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported - Stock Titan

May 08, 2025
pulisher
May 07, 2025

TransCode Therapeutics Faces Nasdaq Delisting Risk - TipRanks

May 07, 2025
pulisher
May 05, 2025

TransCode Therapeutics Announces Reverse Stock Split - TipRanks

May 05, 2025
pulisher
May 05, 2025

TransCode Plans Massive 28:1 Stock Consolidation: What This Means for Your RNAZ Shares - Stock Titan

May 05, 2025
pulisher
May 05, 2025

US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga

May 05, 2025
pulisher
May 05, 2025

Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday - Benzinga

May 05, 2025
pulisher
May 04, 2025

TransCode Therapeutics Announces 1-for-28 Reverse Stock Split - citybiz

May 04, 2025
pulisher
May 03, 2025

TransCode Therapeutics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com India

May 03, 2025
pulisher
May 02, 2025

TransCode Therapeutics (RNAZ) Plans 1-for-28 Reverse Stock Split - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Offerings News Live Feed - Stock Titan

May 02, 2025
pulisher
May 02, 2025

Transcode Therapeutics Announces 1-For-28 Reverse Stock Split - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics (RNAZ) Announces 1-for-28 Reverse Stock Split - GuruFocus

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics approves reverse stock split to meet Nasdaq rules - Investing.com

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics approves 1-for-28 reverse stock split; shares fall - MSN

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics (RNAZ) Plans 1-for-28 Reverse Stock Split | RNAZ Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

TransCode Therapeutics to Implement 1-for-28 Reverse Stock Split - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

TransCode Plans Major 1:28 Reverse Split, Slashing Shares from 23M to 833K for Nasdaq Listing - Stock Titan

May 02, 2025
pulisher
May 02, 2025

TransCode Stock Rallies On Promising Metastatic Cancer Drug Trial: Retail Sees More Upside - MSN

May 02, 2025
pulisher
May 02, 2025

For Dropbox Inc [DBX], Analyst sees a drop to $30. What next? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Direct Digital Holdings Inc [DRCT] is -44.37% lower this YTD. Is it still time to buy? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

CN Energy Group Inc [CNEY] Is Currently 9.75 above its 200 Period Moving Avg: What Does This Mean? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Wall Street Analyst Upgrade Rush Street Interactive Inc [RSI]. What else is Wall St. saying - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

why Kronos Bio Inc [KRON] is a Good Choice for Investors After New Price Target of $1.00 - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Glaukos Corporation [GKOS] Revenue clocked in at $383.48 million, down -44.28% YTD: What’s Next? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Republic Digital Acquisition Company [RDAGU] Stock trading around $10.15 per share: What’s Next? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Venture Global Inc [VG] stock Initiated by UBS analyst, price target now $14 - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Hayward Holdings Inc [HAYW] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Market cap of Solaris Energy Infrastructure Inc [SEI] reaches 1.55B – now what? - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

why Astera Labs Inc [ALAB] is a Good Choice for Investors After New Price Target of $111.21 - dbtnews.com

May 02, 2025
pulisher
May 01, 2025

IBN Coverage: TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138 - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138 - The Globe and Mail

May 01, 2025
pulisher
May 01, 2025

TransCode Therapeutics (RNAZ) Advances Clinical Trial of TTX-MC1 - GuruFocus

May 01, 2025
pulisher
May 01, 2025

TransCode's Cancer Drug Achieves Major Safety Milestone: 13 Patients Show No Toxicity in Latest Trial Data - Stock Titan

May 01, 2025
pulisher
May 01, 2025

EXCLUSIVE: TransCode Therapeutics Reports Progress In Early-Stage Study For Lead Cancer Drug - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Selling Your TransCode Therapeutics Inc (NASDAQ: RNAZ) Stock? Here’s What You Need To Know - Stocksregister

May 01, 2025
pulisher
May 01, 2025

TransCode Therapeutics (RNAZ) Adjourns Special Meeting to May 2 - GuruFocus

May 01, 2025
pulisher
Apr 30, 2025

TransCode Therapeutics Inc (RNAZ) can make a big difference with a little luck - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Does Arbe Robotics Ltd (ARBE) offer a good opportunity for investors? - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

A Look at Murphy Oil Corp (MUR) Shares in the Recent Past Indicates Growth - Sete News

Apr 30, 2025
pulisher
Apr 29, 2025

TransCode Therapeutics Inc (RNAZ) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com

Apr 29, 2025
pulisher
Apr 28, 2025

TransCode Therapeutics stock slides after announces to raise $10M securities offering - MSN

Apr 28, 2025
pulisher
Apr 28, 2025

TransCode Therapeutics Inc (RNAZ) deserves closer scrutiny - uspostnews.com

Apr 28, 2025
pulisher
Apr 28, 2025

Short Interest in TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Decreases By 59.2% - Defense World

Apr 28, 2025
pulisher
Apr 23, 2025

(RNAZ) Trading Signals - news.stocktradersdaily.com

Apr 23, 2025
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Kapitalisierung:     |  Volumen (24h):